Co-Diagnostics, Inc.
CODX
$0.2617
-$0.0179-6.40%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.79% | -6.53% | 3.00% | 0.98% | -22.65% |
| Total Depreciation and Amortization | 6.59% | 11.93% | 9.61% | 3.72% | -7.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -65.04% | -31.78% | -24.22% | -27.69% | -38.88% |
| Change in Net Operating Assets | -50.19% | -51.17% | -46.84% | -81.41% | -53.14% |
| Cash from Operations | -19.29% | -32.03% | -20.60% | -67.98% | -244.60% |
| Capital Expenditure | 72.42% | 45.19% | 4.53% | -1.24% | -31.13% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -81.32% | 6.36% | 159.47% | 158.69% | 164.48% |
| Cash from Investing | -81.66% | 10.93% | 155.58% | 154.49% | 161.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | 93.41% | 97.42% | 94.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 152.01% | 107.62% | 93.41% | 97.42% | 93.99% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -226.62% | -48.70% | 100.78% | 100.04% | 118.38% |